The DOI matches its Crossref record; 343 of the 343 references it cites were found in a registry or an index.
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Abstract
At present, diabetic kidney disease affects about 15-25% of type 1 and 30-40% of type 2 diabetic patients. Several decades of extensive research has elucidated various pathways to be implicated in the development of diabetic kidney disease. This review focuses on the metabolic factors beyond blood glucose that are involved in the pathogenesis of diabetic kidney disease, i.e., advanced glycation end-products and the aldose reductase system. Furthermore, the contribution of hemodynamic factors, the renin-angiotensin system, the endothelin system, and the nitric oxide system, as well as the prominent role of the intracellular signaling molecule protein kinase C are discussed. Finally, the respective roles of TGF-beta, GH and IGFs, vascular endothelial growth factor, and platelet-derived growth factor are covered. The complex interplay between these different pathways will be highlighted. A brief introduction to each system and description of its expression in the normal kidney is followed by in vitro, experimental, and clinical evidence addressing the role of the system in diabetic kidney disease. Finally, well-known and potential therapeutic strategies targeting each system are discussed, ending with an overall conclusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Endothelial dysfunction in diabetes
De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703393 · Cited by 1,165
Self-citationFong, T. A. T., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T., Kim, Y. H., Schreck, R., Wang, X., Risau, W., et al. (1999) · PubMed · Cited by 1,109
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0382 · Cited by 1,079
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,037
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
Robinson, C. J., & Stringer, S. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.853 · Cited by 944
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Flier, J. S., Underhill, L. H., Greene, D. A., Lattimer, S. A., & Sima, A. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161007 · Cited by 897
Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
Specificity, diversity, and regulation in TGF-beta superfamily signaling.
Piek, E., HELDIN, C., & ten Dijke, P. (1999) · PubMed · Cited by 783
Cosentino, F., Hishikawa, K., Katusic, Z. S., & Lüscher, T. F. (1997) · Circulation · doi:10.1161/01.cir.96.1.25 · Cited by 763
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Endothelin System: The Double-Edged Sword in Health and Disease
Kedzierski, R. M., & Yanagisawa, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.851 · Cited by 745
VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells
Hood, J. D., Meininger, C. J., Ziche, M., & Granger, H. J. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.3.h1054 · Cited by 699
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 682
Sharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Specificity, diversity, and regulation in TGF‐β superfamily signaling
PIEK, E., HELDIN, C., & DIJKE, P. T. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 656
Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651
Understanding the nature of renal disease progression
Remuzzi, G., Ruggenenti, P., & Benigni, A. (1997) · Kidney International · doi:10.1038/ki.1997.2 · Cited by 649
Carey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Anchoring proteins for protein kinase C: a means for isozyme selectivity
Mochly-Rosen, D., & Gordon, A. S. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.35 · Cited by 588
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562
Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119503 · Cited by 536
PKCu is a novel, atypical member of the protein kinase C family.
Johannes, F. J., Prestle, J., Eis, S., Oberhagemann, P., & Pfizenmaier, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37580-4 · Cited by 524
TANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Cooper, M. E., Vranes, D., Youssef, S., Stacker, S. A., Cox, A. J., Rizkalla, B., Casley, D. J., Bach, L. A., Kelly, D. J., & Gilbert, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2229 · Cited by 474
Oldfield, M. D., Bach, L. A., Forbes, J. M., Nikolic-Paterson, D., McRobert, A., Thallas, V., Atkins, R. C., Osicka, T., Jerums, G., & Cooper, M. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11951 · Cited by 472
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., et al. (1996) · Nature · doi:10.1038/382275a0 · Cited by 466
The Role of Vascular Endothelial Growth Factor in Angiogenesis
Ferrara, N., & Gerber, H.-P. (2001) · Acta Haematologica · doi:10.1159/000046610 · Cited by 451
Soulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1328 · Cited by 447
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Self-citationIdentification of PKC-isoform-specific biological actions using pharmacological approaches
Way, K. J., Chou, E., & King, G. L. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01468-1 · Cited by 435
Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433 · cited 3×
“Amadori products, pentosidine, CML, pyrraline, and imidazolone were demonstrated in renal tissue of diabetic patients (17, 18).”
BackgroundKOYA, D., HANEDA, M., NAKAGAWA, H., ISSHIKI, K., SATO, H., MAEDA, S., SUGIMOTO, T., YASUDA, H., KASHIWAGI, A., WAYS, D. K., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.439 · Cited by 427
Koller, W. C., Lyons, K., Pahwa, R., & Sf, S. W. (2002) · Cited by 421
Expression of transforming growth factor-β isoforms in human glomerular diseases
Yamamoto, T., Noble, N. A., Cohen, A. H., Nast, C. C., Hishida, A., Gold, L. I., & Border, W. A. (1996) · Kidney International · doi:10.1038/ki.1996.65 · Cited by 418
Hocher, B., Thöne-Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V, Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H. H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 409
Ravid, M., Brosh, D., Levi, Z., Bar-Dayan, Y., Ravid, D., & Rachmani, R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_1-199806150-00004 · Cited by 389
RISER, B. L., DENICHILO, M., CORTES, P., BAKER, C., GRONDIN, J. M., YEE, J., & NARINS, R. G. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11125 · Cited by 388
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 377
Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 376
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
Onozato, M. L., Tojo, A., Goto, A., Fujita, T., & Wilcox, C. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00123.x · Cited by 373
Molecular basis of osmotic regulation
Burg, M. B. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.6.f983 · Cited by 368
Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney
Bachmann, S., Bosse, H. M., & Mundel, P. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.5.f885 · Cited by 362
Biosynthesis and homeostatic roles of nitric oxide in the normal kidney
Kone, B. C., & Baylis, C. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.5.f561 · Cited by 355
Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C., McLaughlin, T., Reaven, G. M., Stuehlinger, M., & Tsao, P. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02063-x · Cited by 354
Doi, T., Vlassara, H., Kirstein, M., Yamada, Y., Striker, G. E., & Striker, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2873 · Cited by 351
Craven, P. A., & DeRubertis, F. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114066 · Cited by 319
Cellular events in the evolution of experimental diabetic nephropathy
Young, B. A., Johnson, R. J., Alpers, C. E., Eng, E., Gordon, K., Floege, J., Couser, W. G., & Seidel, W. T. S. A. F. S. K. (1995) · Kidney International · doi:10.1038/ki.1995.139 · Cited by 318
Expression of the Subtype 2 Angiotensin (AT2) Receptor Protein in Rat Kidney
Ozono, R., Wang, Z.-Q., Moore, A. F., Inagami, T., Siragy, H. M., & Carey, R. M. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1238 · Cited by 317
Yamagishi, S.-I., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., & Makita, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202634200 · Cited by 310
Flyvbjerg, A., Dagnæs-Hansen, F., De Vriese, A. S., Schrijvers, B. F., Tilton, R. G., & Rasch, R. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3090 · Cited by 309
Self-citationmRNA Expression of Growth Factors in Glomeruli From Diabetic Rats
Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Nagaoka, I., Tomino, Y., & Koide, H. (1993) · Diabetes · doi:10.2337/diab.42.3.450 · Cited by 307
Urinary excretion of podocytes in patients with diabetic nephropathy
Nakamura, T., Ushiyama, C., Suzuki, S., Hara, M., Shimada, N., Ebihara, I., & Koide, H. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.9.1379 · Cited by 303
Doi, T., Striker, L. J., Quaife, C. J., Conti, F., Palmiter, R. D., Behringer, R. R., Brinster, R. L., & Striker, G. E. (1988) · PubMed Central · Cited by 299
Williams, B., Gallacher, B., Patel, H., & Orme, C. (1997) · Diabetes · doi:10.2337/diab.46.9.1497 · Cited by 295
Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor
Gilbertson, D. G., Duff, M. E., West, J. W., Kelly, J. D., Sheppard, P. O., Hofstrand, P. D., Gao, Z., Shoemaker, K., Bukowski, T. R., Moore, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101056200 · Cited by 292
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Simon, M., Grone, H. J., Johren, O., Kullmer, J., Plate, K. H., Risau, W., & Fuchs, E. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.2.f240 · Cited by 288
Idris, I., Gray, S., & Donnelly, R. (2001) · Diabetologia · doi:10.1007/s001250051675 · Cited by 285
Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II Diabetes
Sharma, K., Ziyadeh, F. N., Alzahabi, B., McGowan, T. A., Kapoor, S., Kurnik, B. R. C., Kurnik, P. B., & Weisberg, L. S. (1997) · Diabetes · doi:10.2337/diab.46.5.854 · Cited by 274
Distribution of angiotensin AT1and AT2receptor subtypes in the rat kidney
Miyata, N., Park, F., Li, X. F., & Cowley, A. W. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.3.f437 · Cited by 270
Marumo, T., Schini-Kerth, V. B., & Busse, R. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1131 · Cited by 251
Signal transduction via the growth hormone receptor
Zhu, T., Goh, E. L. K., Graichen, R., Ling, L., & Lobie, P. E. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00186-3 · Cited by 247
Nakamura, T., Miller, D., Ruoslahti, E., & Border, W. A. (1992) · Kidney International · doi:10.1038/ki.1992.183 · Cited by 247
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.931 · Cited by 244
Jain, S. K., & Lim, G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00462-7 · Cited by 242
Wendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D’Agati, V., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065100.17349.ca · Cited by 239
Nakamura, S., Makita, Z., Ishikawa, S., Yasumura, K., Fujii, W., Yanagisawa, K., Kawata, T., & Koike, T. (1997) · Diabetes · doi:10.2337/diab.46.5.895 · Cited by 235
Expression of transforming growth factor-β1 during diabetic renal hypertrophy
Shankland, S. J., Scholey, J. W., Ly, H., & Thai, K. (1994) · Kidney International · doi:10.1038/ki.1994.291 · Cited by 233
Yokoyama, H., Okudaira, M., Otani, T., Sato, A., Miura, J., Takaike, H., Yamada, H., Muto, K., Uchigata, Y., Ohashi, Y., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00166.x · Cited by 226
Soulis, T., Thallas, V., Youssef, S., Gilbert, R. E., McWilliam, B. G., Cooper, M. E., & Murray-McIntosh, R. P. (1997) · Diabetologia · doi:10.1007/s001250050725 · Cited by 222
Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.
Koya, D., Lee, I. K., Ishii, H., Kanoh, H., & King, G. L. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v83426 · Cited by 218
Tsuchida, K., Makita, Z., Yamagishi, S., Atsumi, T., Miyoshi, H., Obara, S., Ishida, M., Ishikawa, S., Yasumura, K., & Koike, T. (1999) · Diabetologia · doi:10.1007/s001250051198 · Cited by 215
Role of EDRF (nitric oxide) in diabetic renal hyperfiltration
Bank, N., & Aynedjian, H. S. (1993) · Kidney International · doi:10.1038/ki.1993.183 · Cited by 211
Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy
Wang, S., Denichilo, M., Brubaker, C., & Hirschberg, R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00776.x · Cited by 208
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 206
Podocyte Injury Promotes Progressive Nephropathy in Zucker Diabetic Fatty Rats
Hoshi, S., Shu, Y., Yoshida, F., Inagaki, T., Sonoda, J., Watanabe, T., Nomoto, K.-I., & Nagata, M. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780392 · Cited by 205
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
Rossing, K., Christensen, P. K., Jensen, B. R., & Parving, H.-H. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.95 · Cited by 205
AGEs induce oxidative stress and activate protein kinase C-βIIin neonatal mesangial cells
Scivittaro, V., Ganz, M. B., & Weiss, M. F. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f676 · Cited by 204
Gilbert, R. E., Cox, A., Wu, L. L., Allen, T. J., Hulthen, U. L., Jerums, G., & Cooper, M. E. (1998) · Diabetes · doi:10.2337/diabetes.47.3.414 · Cited by 203
Flyvbjerg, A. (2000) · Diabetologia · doi:10.1007/s001250051515 · Cited by 203
Self-citationGrowth Hormone, the Insulin-Like Growth Factor System, and the Kidney*
FELD, S., & HIRSCHBERG, R. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-423 · Cited by 202
DIABETES, DIABETIC ANGIOPATHY, AND GROWTH HORMONE
Lundbæk, K., Jensen, V., STEEN OLSEN, T., Ørskov, H., JUEL CHRISTENSEN, N., Johansen, K., PRANGE HANSEN, Å., & Østerby, R. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92706-6 · Cited by 201
Barton, M., Shaw, S., d'uscio, L. V., Moreau, P., & Lüscher, T. F. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7394 · Cited by 198
Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.
Singh, R., Alavi, N., Singh, A. K., & Leehey, D. J. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2066 · Cited by 197
Jehle, P., Jehle, D., Mohan, S., & Bohm, B. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590297 · Cited by 197
Niwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T., Ishizaki, Y., Hayase, F., Tatemichi, N., & Takei, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119285 · Cited by 196
TANNENBAUM, G. S. (1981) · Endocrinology · doi:10.1210/endo-108-1-76 · Cited by 195
Won Hong, S., Isono, M., Chen, S., Iglesias-de la Cruz, M. C., Han, D. C., & Ziyadeh, F. N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64121-1 · Cited by 194
Cheng, H.-F., Wang, C. J., Moeckel, G. W., Zhang, M.-Z., Mckanna, J. A., & Harris, R. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00520.x · Cited by 193
Paradoxes of nitric oxide in the diabetic kidney
Komers, R., & Anderson, S. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00265.2002 · Cited by 191
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187
Self-citationIsshiki, K., Haneda, M., Koya, D., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.6.1022 · Cited by 184
Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.
Shulman, K., Rosen, S., Tognazzi, K., Manseau, E. J., & Brown, L. F. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v75661 · Cited by 183
Nitric Oxide Synthase Isoforms and Glomerular Hyperfiltration in Early Diabetic Nephropathy
VEELKEN, R., HILGERS, K. F., HARTNER, A., HAAS, A., BO[Combining Diaeresis]HMER, K. P., & STERZEL, R. B. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11171 · Cited by 181
Sharma, K., & Ziyadeh, F. N. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.267.6.f1094 · Cited by 181
Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus
Iwano, M., Kubo, A., Nishino, T., Sato, H., Nishioka, H., Akai, Y., Kurioka, H., Fujii, Y., Kanauchi, M., Shiiki, H., et al. (1996) · Kidney International · doi:10.1038/ki.1996.162 · Cited by 180
Gilbert, R. E., Kelly, D. J., Cox, A. J., Wilkinson-Berka, J. L., Rumble, J. R., Osicka, T., Panagiotopoulos, S., Lee, V., Hendrich, E. C., Jerums, G., et al. (2000) · Diabetologia · doi:10.1007/s001250051539 · Cited by 179
Webb, B. L. J., Hirst, S. J., & Giembycz, M. A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703452 · Cited by 178
Chan, J. C. N., Ko, G. T. C., Leung, D. H. Y., Cheung, R. C. K., Cheung, M. Y. F., So, W.-Y., Swaminathan, R., Nicholls, M. G., Critchley, J. A. J. H., & Cockram, C. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00879.x · Cited by 177
Throckmorton, D. C., Brogden, A. P., Min, B., Rasmussen, H., & Kashgarian, M. (1995) · Kidney International · doi:10.1038/ki.1995.274 · Cited by 174
Doi, T., Striker, L. J., Gibson, C. C., Agodoa, L. Y. C., Brinster, R. L., & Striker, G. E. (1990) · Europe PMC (PubMed Central) · Cited by 167
Kelly, D. J., Zhang, Y., Hepper, C., Gow, R. M., Jaworski, K., Kemp, B. E., Wilkinson-Berka, J. L., & Gilbert, R. E. (2003) · Diabetes · doi:10.2337/diabetes.52.2.512 · Cited by 166
Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor
Iijima, K., Yoshikawa, N., Connolly, D. T., & Nakamura, H. (1993) · Kidney International · doi:10.1038/ki.1993.337 · Cited by 164
Elevated plasma endothelin-1 levels in diabetes mellitus
Schneider, J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03060-1 · Cited by 164
Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C., McLaughlin, T., Cooke, J. P., Reaven, G. M., & Tsao, P. S. (2002) · Metabolism · doi:10.1053/meta.2002.33349 · Cited by 164
Sharma, K., Eltayeb, B. O., McGowan, T. A., Dunn, S. R., Alzahabi, B., Rohde, R., Ziyadeh, F. N., & Lewis, E. J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70037-5 · Cited by 161
Renoprotective effects of a novel inhibitor of advanced glycation
Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G., & Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250051587 · Cited by 161
Sugimoto, H., Shikata, K., Matsuda, M., Kushiro, M., Hayashi, Y., Hiragushi, K., Wada, J., & Makino, H. (1998) · Diabetologia · doi:10.1007/s001250051088 · Cited by 161
Mandriota, S. J., Menoud, P.-A., & Pepper, M. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11500 · Cited by 160
Costantino, L., Rastelli, G., Vianello, P., Cignarella, G., & Barlocco, D. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199901)19:1<3::aid-med2>3.0.co;2-7 · Cited by 159
Soulis, T., Cooper, M. E., Vranes, D., Bucala, R., & Jerums, G. (1996) · Kidney International · doi:10.1038/ki.1996.358 · Cited by 158
Angiotensin II and its receptors in the diabetic kidney
Burns, K. D. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16192 · Cited by 158
Flyvbjerg, A., Bennett, W. F., Rasch, R., Kopchick, J. J., & Scarlett, J. A. (1999) · Diabetes · doi:10.2337/diabetes.48.2.377 · Cited by 158
Self-citationAso, Y., Inukai, T., Tayama, K., & Takemura, Y. (2000) · Acta Diabetologica · doi:10.1007/s005920070025 · Cited by 157
Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 152
Angiotensin II induces apoptosis in renal proximal tubular cells
Bhaskaran, M. C., Reddy, K., Radhakrishanan, N., Franki, N., Ding, G., & Singhal, P. C. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00246.2002 · Cited by 152
Bereket, A., Lang, C. H., & Wilson, T. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978716 · Cited by 151
Pupilli, C., Lasagni, L., Romagnani, P., Bellini, F., Mannelli, M., Misciglia, N., Mavilia, C., VELLEI, U., Villari, D., & Serio, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102245 · Cited by 151
Nitric Oxide Synthesis and Oxidative Stress in the Renal Cortex of Rats with Diabetes Mellitus
Ishii, N., Patel, K. P., Lane, P. H., Taylor, T. A., Bian, K., Murad, F., Pollock, J. S., & Carmines, P. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1281630 · Cited by 148
Cohen, M. P., Sharma, K., Jin, Y. S., Hud, E., Wu, V.-Y., Tomaszewski, J., & Ziyadeh, F. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117926 · Cited by 148
Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis
Furusu, A., Miyazaki, M., Abe, K., Tsukasaki, S., Shioshita, K., Sasaki, O., Miyazaki, K., Ozono, Y., Koji, T., Harada, T., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00907.x · Cited by 146
Chiarelli, F., Cipollone, F., Romano, F., Tumini, S., Costantini, F., di Ricco, L., Pomilio, M., Pierdomenico, S. D., Marini, M., Cuccurullo, F., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1258 · Cited by 146
Immunohistochemical Localization of Aldose Reductase: II. Rat Eye and Kidney
Ludvigson, M. A., & Sorenson, R. L. (1980) · Diabetes · doi:10.2337/diab.29.6.450 · Cited by 146
Nakamura, T., Ebihara, I., Fukui, M., Tomino, Y., & Koide, H. (1995) · Diabetes · doi:10.2337/diab.44.8.895 · Cited by 145
Wang, S., LaPage, J. A., & Hirschberg, R. R. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00928.x · Cited by 145
Role of vascular endothelial growth factor in diabetic nephropathy
Cha, D. R., Kim, N. H., Yoon, J., Jo, S., Cho, W. Y., Kim, H. K., & Won, N. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07717.x · Cited by 142
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy
Hovind, P. H., Tarnow, L., Oestergaard, P. B., & Parving, H. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07504.x · Cited by 142
Simon, M., Röckl, W., Hornig, C., Gröne, E., Theis, H., Weich, H. A., Fuchs, E., Yayon, A., & Gröne, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961032 · Cited by 141
Growth Hormone Binding Protein 2001
Baumann, G. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.4.355 · Cited by 139
Komers, R., Allen, T. J., & Cooper, M. E. (1994) · Diabetes · doi:10.2337/diab.43.10.1190 · Cited by 139
Physiology and pathology of endothelin-1 in renal mesangium
Sorokin, A., & Kohan, D. E. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00019.2003 · Cited by 139
Park, C. W., Kim, J., Lee, J. W., Kim, Y. S., Ahn, H. J., Shin, Y. S., Kim, S.-Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2000) · Diabetologia · doi:10.1007/s001250051567 · Cited by 138
Soulis, T., Cooper, M. E., Dunlop, M., & Jerums, G. (1995) · Diabetologia · doi:10.1007/bf00410275 · Cited by 136
Pugliese, G., Pricci, F., Romeo, G. R., Pugliese, F. R., Mené, P., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., Vlassara, H., et al. (1997) · Diabetes · doi:10.2337/diab.46.11.1881 · Cited by 135
Paolo, S. D., Gesualdo, L., Ranieri, E., Grandaliano, G., & Schena, F. P. (1996) · Europe PMC (PubMed Central) · Cited by 133
Chiarelli, F., Spagnoli, A., Basciani, F., Tumini, S., Mezzetti, A., Cipollone, F., Cuccurullo, F., Morgese, G., & Verrotti, A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00350.x · Cited by 133
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat
Zimpelmann, J., Kumar, D., Levine, D. Z., Wehbi, G. J., Imig, J. D., Navar, L. G., & Burns, K. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00416.x · Cited by 133
Cao, Z., Kelly, D. J., Cox, A. J., CASLEY, D. J., Forbes, J. M., Martinello, P., Dean, R. G., Gilbert, R. E., & Cooper, M. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00427.x · Cited by 133
Craven, P. A., Studer, R., & DeRubertis, F. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116961 · Cited by 130
Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells
Kanellis, J., Fraser, S. A., Katerelos, M., & Power, D. A. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.6.f905 · Cited by 129
Craven, P. A., DeRubertis, F. R., Kagan, V. E., Melhem, M. F., & Studer, R. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891405 · Cited by 129
Conti, F., Striker, L. J., Lesniak, M. A., et al. (1988) · Endocrinology · doi:10.1210/endo-122-6-2788 · Cited by 128
Studer, R., Craven, P. A., & DeRubertis, F. R. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90080-9 · Cited by 128
Alpers, C. E., Seifert, R. A., Hudkins, K. L., Johnson, R. J., & Bowen‐Pope, D. F. (1992) · Kidney International · doi:10.1038/ki.1992.300 · Cited by 128
Glucose scavenging of nitric oxide
Brodsky, S. V., Morrishow, A. M., Dharia, N., Gross, S. S., & Goligorsky, M. S. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f480 · Cited by 128
Osicka, T. M., Yu, Y., Panagiotopoulos, S., Clavant, S. P., Kiriazis, Z., Pike, R. N., Pratt, L. M., Russo, L. M., Kemp, B. E., Comper, W. D., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.1.87 · Cited by 128
Kelly, D. J., Gilbert, R. E., Cox, A. J., Soulis, T., Jerums, G., & Cooper, M. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102098 · Cited by 128
Jones, S. C., Saunders, H. J., Wu, Q., & Pollock, C. A. (1999) · Diabetologia · doi:10.1007/s001250051279 · Cited by 127
Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects
Maejima, K., Nakano, S., Himeno, M., Tsuda, S.-I., Makiishi, H., Ito, T., Nakagawa, A., Kigoshi, T., Ishibashi, T., Nishio, M., et al. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00144-1 · Cited by 126
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
Jacobsen, P. K. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.6.1019 · Cited by 125
Berg, T. J., Bangstad, H. ‐., Torjesen, P. A., Østerby, R., Bucala, R., & Hanssen, K. F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90010-x · Cited by 124
Ziyadeh, F. N., Han, D. C., Cohen, J. A., Guo, J., & Cohen, M. P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00815.x · Cited by 124
Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
Gröne, H., Simon, M., & Gröne, E. F. (1995) · The Journal of Pathology · doi:10.1002/path.1711770308 · Cited by 124
Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO
Tolins, J. P., Shultz, P. J., Raij, L. R., Brown, D. M., & Mauer, S. M. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.6.f886 · Cited by 123
Awad, B. E., Kreft, B., Wolber, E., Hellwig‐Bürgel, T., Metzen, E., Fandrey, J., & JELKMANN, W. E. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00139.x · Cited by 120
Gilbert, R. E., Kelly, D. J., Mckay, T., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041324.x · Cited by 119
PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF
Choudhury, G. G., Karamitsos, C., Hernandez, J., Gentilini, A., Bardgette, J., & Abboud, H. E. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.6.f931 · Cited by 119
Marti, H., Lee, L., Kashgarian, M. J., & Lovett, D. H. (1994) · PubMed · Cited by 118
Zhang, S., Filep, J. G., Hohman, T. C., Tang, S., Ingelfinger, J. R., & Chan, J. S. D. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00271.x · Cited by 118
Blom, I. E., van Dijk, A. J., Wieten, L., Duran, K. J., Ito, Y., Kleij, L., DeNichilo, M. O., Rabelink, T. J., Weening, J. J., Aten, J., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.6.1139 · Cited by 118
Yoshimoto, T., Naruse, M., Nishikawa, M., Naruse, K., Tanabe, A., Seki, T., Imaki, T., Demura, R., Aikawa, E., & Demura, H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.6.e989 · Cited by 117
Hill, C., Flyvbjerg, A., Grønbæk, H., Petrik, J., Hill, D. J., Thomas, C. R., Sheppard, M. C., & Logan, A. (2000) · Endocrinology · doi:10.1210/endo.141.3.7359 · Cited by 114
Self-citationGene expression of the renin-angiotensin system in human kidney
Lai, K. N., Leung, J. C. K., Lai, K. B., To, W. Y., Yeung, V. T. F., & Lai, F. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816010-00014 · Cited by 114
Chen, S., Cohen, M. P., Lautenslager, G. T., Shearman, C. W., & Ziyadeh, F. N. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002673.x · Cited by 113
Evidence for Existence of Polyol Pathway in Cultured Rat Mesangial Cells
Kikkawa, R., Umemura, K., Haneda, M., Arimura, T., Ebata, K., & Shigeta, Y. (1987) · Diabetes · doi:10.2337/diab.36.2.240 · Cited by 113
Angiotensin II Increases Connective Tissue Growth Factor in the Kidney
Rupérez, M., Ruiz‐Ortega, M., Esteban, V., Lorenzo, Ó., Mezzano, S. A., Plaza, J. J. G., & Egido, J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63552-3 · Cited by 112
Editorial: Insulin-Like Growth Factor I Receptor Signaling—Overlapping or Redundant Pathways?
LeRoith, D. (2000) · Endocrinology · doi:10.1210/endo.141.4.7475 · Cited by 112
O'Hare, P. J., Bilbous, R., Mitchell, T., Callaghan, C. J. O., Viberti, G. C., & Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1823 · Cited by 109
Gruden, G., Thomas, S., Burt, D. J., ZHOU, W., Chusney, G. D., Gnudi, L., & Viberti, G. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104730 · Cited by 108
Floege, J., Johnson, R. J., Alpers, C. E., Fatemi-Nainie, S., Richardson, C. A., Gordon, K. R., & Couser, W. G. (1993) · PubMed · Cited by 107
Komers, R., Lindsley, J. N., Oyama, T., Allison, K. M., & Anderson, S. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f573 · Cited by 107
Montero, A., Munger, K. A., Khan, R. Z., Valdivielso, J. M., Morrow, J. D., Guasch, A., Ziyadeh, F. N., & Badr, K. F. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00368.x · Cited by 106
Mechanisms of Mitogen-Activated Protein Kinase Activation in Experimental Diabetes
Awazu, M., Ishikura, K., Hida, M., & Hoshiya, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104738 · Cited by 106
Wilkinson‐Berka, J. L., Kelly, D. J., Koerner, S. M., Jaworski, K., Davis, B., Thallas, V., & Cooper, M. E. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3283 · Cited by 105
Han, D. C., Hoffman, B. B., Hong, S. W., Guo, J., & Ziyadeh, F. N. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f628 · Cited by 105
Parving, H., Hommel, E. E., Jensen, B. R., & Hansen, H. P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00790.x · Cited by 104
Gesualdo, L., Paolo, S. D., Milani, S., Pinzani, M., Grappone, C., Ranieri, E., Pannarale, G., & Schena, F. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117348 · Cited by 104
Kelly, D. J., Skinner, S. L., Gilbert, R. E., Cox, A. J., Cooper, M. E., & Wilkinson‐Berka, J. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00038.x · Cited by 103
Rudberg, S. L., Østerby, R., Bangstad, H. ‐., Dahlquist, G. G., & Persson, B. (1999) · Diabetologia · doi:10.1007/s001250051199 · Cited by 102
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Chronic Kidney Disease and Exposure to Nephrotoxic Metals
Orr, S., & Bridges, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051039 · Cited by 434
The role of the complement system in diabetic nephropathy
Flyvbjerg, A. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.31 · Cited by 397
Self-citationAdvanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 387
Metadata
- Authors
- Schrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-12-01
- Volume
- 25
- Issue
- 6
- Pages
- 971-1010
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2105487207
- Cited by
- 353
- References
- 343
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.